Preliminary Evaluation of SGLT2 Inhibitors in Human Bladder Cancer T24 Cells. Szachniewicz M, Baran M, Gagat M, Halas-Wisniewska M, et al. Biomedicines 2026;14:2037.

Read + Share

Amedeo Smart

Independent Medical Education

Szachniewicz M, Baran M, Gagat M, Halas-Wisniewska M, et al. Preliminary Evaluation of SGLT2 Inhibitors in Human Bladder Cancer T24 Cells. Biomedicines 2026;14:2037.
PMID: 42792778